Objectives: Specifically here we report about different in vitro experimental models, based on human cells.
Introduction: Hyaluronic acid (HA) is a naturally occurring biodegradable polymer with several biological applications in medicine including tissue engineering, dermatological fillers, and viscosupplementation for osteoarthritis treatment. Size dependent bioactivity has been recently approached in the scientific literature. Starting from the concept that the human skin has different layers and covers muscles and fat compartment, with a layer by layer approach we intended to analyse in vitro the potentialities of hyaluronan gels, and specifically of the novel High and low molecular weight HA complexes (HCC)
Materials / method: First: keratinocycets, fibroblasts and their co-culture. In addition 3D specific models were implemented for in vitro studies of the epidermal layer. Second: Adipose stem cells (ASCs) differentiation and proliferation were analyzed to establish biological activity of HCCs in subcutaneous compartment. Third: Mesenchymal stem cells, present in the stroma of the tissues, were used to study HCC effect on senescence. Finally, we are studying the HCC properties on muscle like cells. Specifically, we are evaluating the ability of hyaluronan based formulations to counteract the oxidative stress and
Results: Data showed that hybrid complexes proved to better promote wound healing of human keratinocytes in vitro respect to linear HA and supporting the clinically observed improvement of skin elasticity. In addition HCCs-based formulations clearly enhance adipogenic differentiation and proliferation, provide an appropriate microenvironment for MSC growth, by preserving their differentiation and senescence when compared with linear HA.
Conclusion: HCC proved to perform better than HA alone thus suggesting their potential as medical devices in aesthetic and regenerative medicine.
Divulgação de informações
Você recebeu algum patrocínio para sua pesquisa neste tema?
Sim
Por favor indique a entidade (pessoa ou empresa): Prof. Schiraldi and her group declare that they have no competing interest. Prof. Schiraldi and her group have been involved in research projects funded by the Ministry of Education (MIUR) and/or Regione Campania involving industrial partners, among which are Altergon s.r.l. and IBSA ITALIA, that also supported Bioteknet for some inherent studies
Você recebeu algum tipo de honorário, pagamento ou outra forma de compensação por seu trabalho neste estudo?
Não
Você possui relação financeira com alguma entidade que possa competir com os medicamentos, materiais ou instrumentos abordados no seu estudo?
Não
Você detém ou pediu a registro de patente para algum dos instrumentos, medicamentos ou materiais abordados no seu estudo?
Não
Este trabalho foi realizado com o patrocínio de: Prof De Rosa and Prof. Schiraldi and her group have been involved in research projects funded by the Ministry of Education (MIUR) and/or Regione Campania involving industrial partners, among which are Altergon s.r.l. and IBSA ITALIA, that also supported B
